Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: Role of Kupffer cells

Hepatology

Volumn 29, Issue 3, 1999, Pages 737-745

  Stachlewitz, Robert F ^a   Seabra, Vitor ^a   Bradford, Blair ^a   Bradham, Cynthia A ^a   Rusyn, Ivan ^a,b   Germolec, Dori ^c   Thurman, Ronald G ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHLORIDE; GALACTOSAMINE; GLYCINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; URIDINE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033055874     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290335     Document Type: Article

References (15)

1. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 1968;9:279-290.
2. Jonker AM, Dijkhuis FWJ, Kroese FGM, Hardonk MJ, Grond J. Immunopathology of acute galactosamine hepatitis in rats. HEPATOLOGY 1990;11:622-627.
3. MacDonald JR, Beckstead JH, Smuckler EA. An ultrastructural and histochemical study of the prominent inflammatory response in D(+)-galactosamine hepatotoxicity. Br J Exp Pathol 1987;68:189-199.
4. Zimmerman HJ. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. New York: Appleton-Century-Crofts, 1978.
5. Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974;71:78-106.
6. Decker K, Keppler D. Galactosamine induced liver injury. Prog Liver Dis 1972;4:183-199.
7. Shinozuka H, Farber JL, Konishi Y, Anukarhanonta T. D-galactosamine and acute liver cell injury. Fed Proc 1973;32:1516-1526.
8. Holstege A, Anukarhanonta T, Yamamoto M, Koch HK, Katterman R, Lesch R, Keppler D. Preventive effects of 5-fluorouridine and uridine on D-galactosamine-induced liver injury. Exp Mol Pathol 1981;34:170-182.
9. Keppler D, Decker K. Studies on the mechanism of galactosamine hepatitis: accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem 1969;10:219-225.
10. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization tothe lethal effects of endotoxin. Proc Natl Acad Sci 1979;76:5939-5943.
11. Liehr H, Grun M, Seeling H. On the pathogenesis of galactosamine hepatitis. Virchows Arch B Cell Pathol 1978;26:331-335.
12. Shiratori Y, Kawase T, Shina S, Okano K, Sugimoto T, Teraoka H, Matano S, et al. Modulation of hepatotoxicity by macrophages in the liver. HEPATOLOGY 1988;8:815-821.
13. Kasravi FB, Wang L, Wang X, Molin G, Bengmark S, Jeppsson B. Bacterial translocation in acute liver injury induced by D-galactosamine. HEPATOLOGY 1996;23:97-103.
14. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989;38:627-631.
15. Leist M, Ganter F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-1234.